You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Quantum and Nanostructure Enhanced Epitaxial Lift-Off Solar Cells

    SBC: MICROLINK DEVICES INC            Topic: AF13AT13

    ABSTRACT: MicroLink and its collaborators, Rochester Institute of Technology and Magnolia Solar, will develop a high-efficiency, single-junction, epitaxial lift-off (ELO) GaAs solar cell by incorporating nano-scale features, such as quantum dots and optically functional textures, within the solar cell structure. The principal technical objective of the project is to increase the AM0 efficiency o ...

    STTR Phase I 2014 Department of DefenseAir Force
  2. Nonequilibrium Plasma-Assisted Combustion-Efficiency Control in Vitiated Air

    SBC: CU AEROSPACE L.L.C.            Topic: AF13AT04

    ABSTRACT: CU Aerospace (CUA) and team partner the University of Illinois at Urbana-Champaign (UIUC) propose to perform research, development and demonstration of experimental quenching free measurements of heat-release in a realistic highly turbulent plasma-assisted flame. Kinetics models will be correspondingly updated and detailed 3D multiphysics simulations will be validated by the measuremen ...

    STTR Phase I 2014 Department of DefenseAir Force
  3. Microvascular Composites for Novel Thermal Management Devices

    SBC: CU AEROSPACE L.L.C.            Topic: AF13AT09

    ABSTRACT: Living systems rely on pervasive vascular networks to enable a plurality of biological function, exemplified by natural composite structures that are lightweight, high-strength, and capable of mass and energy transport. In contrast, synthetic composites possess high strength-to-weight ratios but lack the dynamic functionality of their natural counterparts. CU Aerospace, with team partne ...

    STTR Phase I 2014 Department of DefenseAir Force
  4. Physical Sub-Model Development for Turbulence Combustion Closure

    SBC: CORVID TECHNOLOGIES, LLC            Topic: AF13AT12

    ABSTRACT: Corvid Technologies, in partnership with Clemson University"s combustion modeling group, is pleased to offer a physical sub-model evaluation and development plan for turbulent combustion applications relevant to the Air Force. We will leverage the computational resources and combustion modeling expertise from both parties to evaluate the current state of combustion modeling and then tra ...

    STTR Phase I 2014 Department of DefenseAir Force
  5. Secure Efficient Cross-domain Protocols

    SBC: SONALYSTS INC            Topic: AF13AT08

    ABSTRACT: The Sonalysts team proposes to develop a solution that facilitates the flow of data between different levels of classification while improving and ensuring both security and data integrity. Our approach involves a set of protocols that provide a unique and disruptive combination of multichannel data dispersion and multi-classification data management techniques to meet our objectives. ...

    STTR Phase I 2014 Department of DefenseAir Force
  6. New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cyto

    SBC: Nirvana Sciences, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Polychromatic flow cytometry [FC] is one of the most powerful analytical techniques routinely used in immunology. Flow cytometry plays a critical role in several growing clinical applications: leukemia and lymphoma immunophenotyping for diagnosis and sub-categorization (now using 8-10 colors); in CD4/CD8 measurement in HIV-positive patients; and in HLA typing f ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Non-ATP competitive inhibitors of cyclin dependent kinases as cancer therapeutics

    SBC: PPI PHARMACEUTICALS, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): As cancer is one of the leading causes of death in the United States with some sub-types remaining essentially untreatable, expansion of available drug targets will provide significant new options for the development ofmore effective antineoplastic agents. The major goal of this project is to apply a unique drug discovery strategy to cancer drug development. Th ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. AAV2-ASPA-Based Metabolic Intervention for Alzheimer's Disease

    SBC: ASKLEPIOS BIOPHARMACEUTICAL, INC.            Topic: NIA

    Abstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International's report on Dementia (2012) recognizes that the global burden of AlzheimerDisease is forecast to worsen significantly with prevalence predicted to double every 20 years. Interventions that could prov ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Removal of Amyloid-beta Peptides from the Alzheimer's Brain

    SBC: WE BIOSCIENCES, LLC            Topic: NIA

    DESCRIPTION (provided by applicant): As the Alzheimer's disease (AD) population is growing rapidly, currently there are no cure treatments. The goal of this resubmitted STTR proposal is to conduct a preclinical study with pramlintide to prove a potential treatment for AD. We have revised the proposal significantly according to the reviewers' comments. Pramlintide is an FDA approved drug ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Topically-delivered Targeted Gene Suppression of Immune Activation in Psoriasis

    SBC: Exicure, Inc.            Topic: NIAMS

    DESCRIPTION (provided by applicant): AuraSense Therapeutics (AST), along with Northwestern University, is applying a recently developed technology using oligonucleotide-functionalized nanoparticles (called spherical nucleic acids or SNAs) to control protein expression. These easily synthesized nanoparticles can have either DNA or RNA shells, and are less than 50 nm in hydrodynamic diameter. SNA co ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government